Effect in vitro and in vivo of a rat anti-CD2 monoclonal antibody (LO-CD2b) on pig to baboon xenogeneic cellular (T and natural killer cells) immune response

被引：0
作者：
Dehoux, JP [1 ]
de la Parra, B [1 ]
Latinne, D [1 ]
Bazin, H [1 ]
Gianello, P [1 ]
机构：
[1] Catholic Univ Louvain, B-3000 Louvain, Belgium
来源：
XENOTRANSPLANTATION | 2001年 / 8卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
406
引用
收藏
页码：79 / 79
页数：1
相关论文
共 50 条
  • [31] INCREASED SURFACE EXPRESSION OF CD11B/C AND CD18 APPEARS TO BE DISSOCIATED FROM ANTI-CD11B/C MONOCLONAL-ANTIBODY STIMULATED O2-, ANION GENERATION IN IN-VIVO ESCHERICHIA-COLI LIPOPOLYSACCHARIDE AND TUMOR NECROSIS FACTOR-ALPHA-TREATED RAT NEUTROPHILS
    MAYER, AMS
    ZHANG, P
    SPITZER, JA
    SHOCK, 1994, 2 (04): : 289 - 295
  • [32] Anti-KIR(1-7F9): A fully human monoclonal antibody (mAb) that blocks KIR2DL1,-2 and-3, promoting natural killer (NK) cell-mediated lysis of tumor cells in vitro and in vivo
    Wagtmann, Nicolai
    Andre, Pascale
    Zahn, Stefan
    Spee, Pieter
    Anfossi, Nicolas
    Gauthier, Laurent
    Blaser, Bradley W.
    Caligiuri, Michael A.
    Capanni, Marusca
    Ruggeri, Loredana
    Velardi, Andrea
    Romagne, Francois
    BLOOD, 2007, 110 (11) : 179A - 179A
  • [33] Ex vivo expansion (EvE) and activation of a unique population of neonatal natural killer (NK) cells by anti-CD3, IL-2, IL-7 and IL-12: Potential for adoptive cellular immunotherapy (ACI)
    Ayello, J
    Satwani, P
    Ven, CV
    Cairo, MS
    PEDIATRIC RESEARCH, 2004, 55 (04) : 402A - 402A
  • [34] T cell-derived IL-2 costimulates CD56bright human natural killer (NK) cell interferon gamma (IFN-γ) production:: In vitro evidence that antigen-specific immune effector cells can regulate the innate immune response.
    Fehniger, TA
    Cooper, MA
    Cella, M
    Ponnappan, A
    Carson, WE
    Caligiuri, MA
    BLOOD, 1999, 94 (10) : 7A - 7A
  • [35] Infusions of T cells armed with anti-CD3 x anti-Her2/neu bispecific antibody modulate in vivo patient immune responses in phase I clinical trials for breast and hormone refractory prostate cancers.
    Davol, PA
    Gall, JM
    Grabert, RC
    Young, WB
    Curnmings, FJ
    Rathore, R
    Colvin, GA
    Elfenbein, GJ
    Lum, LG
    BLOOD, 2004, 104 (11) : 379A - 379A
  • [36] REGULATION OF CYTOKINES/CHEMOKINES RELEASE AND ANTI-TUMOR EFFECT OF EXPANDED NATURAL KILLER (NK) CELLS BY A NOVEL FUSION OF N-820 (2B8T2M), AN IL-15 SUPERAGONIST WITH 4 SINGLE-CHAIN ANTI-CD20 ANTIBODY DOMAINS, AGAINST RITUXIMAB RESISTANT BURKITT LYMPHOMA (BL)
    Chu, Yaya
    Negron, Olivia
    Nayyar, Gaurav
    Rosenblum, Jeremy
    Jeng, Emily
    Alter, Sarah
    Rhode, Peter R.
    Lee, Dean A.
    Wong, Hing C.
    Lee, John H.
    Cairo, Mitchell S.
    PEDIATRIC BLOOD & CANCER, 2019, 66
  • [37] Regulation of Cytokines/Chemokines Release and Anti-Tumor Effect of Expanded Natural Killer (NK) Cells By a Novel Fusion of N-820 (2B8T2M), an IL-15 Superagonist with 4 Single-Chain Anti-CD20 Antibody Domains, Against Rituximab Resistant Burkitt Lymphoma (BL)
    Chu, Yaya
    Su, Nang Kham
    Jeng, Emily K.
    Alter, Sarah
    Rhode, Peter R.
    Lee, John H.
    Nayyar, Gaurav
    Barth, Matthew J.
    Lee, Dean Anthony
    Wong, Hing C.
    Cairo, Mitchell
    BLOOD, 2018, 132
  • [38] Two Are Better than One: The Bi-Specific Antibody Mosunetuzumab Reveals an Improved Immune Response of Vγ9Vδ2 T Cells Targeting CD20 in Malignant B Cells in Comparison to the Mono-Specific Antibody Obinutuzumab
    Marischen, Lothar
    Fritsch, Juergen
    Ilic, Jovana
    Wahl, Laura
    Bertsch, Thomas
    Knop, Stefan
    Bold, Anna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (03)
  • [39] Cytokines and chemokines released from the interaction of anti-HER2/anti-CD3 bispecific antibody armed activated T cells (ATC) with the tumor microenvironment can induce efficient antigen presentation and induce an adaptive immune response
    Al-Kadhimi, Z.
    Paul, E.
    Norkina, O.
    Lum, L. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [40] LYSIS OF FRESH SOLID TUMOR TARGETS IN THE PRESENCE OF CON A IS MEDIATED PRIMARILY BY LEU-7+ PERIPHERAL-BLOOD LYMPHOCYTES-T - BLOCKING BY THE ANTI-CD3 MONOCLONAL-ANTIBODY AND COMPARISON WITH RECOMBINANT INTERLEUKIN-2-INDUCED LYSIS BY NATURAL-KILLER-CELLS
    ITOH, K
    PLATSOUCAS, CD
    TILDEN, AB
    POLLOCK, RE
    BALCH, CM
    CELLULAR IMMUNOLOGY, 1987, 108 (02) : 283 - 296
12345